Skip to main content
BSX
NYSE Life Sciences

Blackstone Puts $455M Behind Boston Scientific's VITALYST Heart Pump

Tom Rudovsky · Reported by BusinessWire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$44.16
Mkt Cap
$64.23B
52W Low
$39.57
52W High
$105.65
52W Position info
12% above low
Off High info
58% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

BSX is trading near its 52-week low of $39.57 (12% above the low).

Summary

Blackstone Life Sciences committed $455 million to co-fund development of Boston Scientific's VITALYST temporary heart pump, a miniature circulatory support device aimed at acute myocardial infarction cardiogenic shock. It's the first time the two have co-funded a Boston Scientific product, so Blackstone is taking on a chunk of the development cost and risk for a program still in development. The money is modest next to Boston Scientific's scale, but it validates the VITALYST program and offloads spend on a device that won't contribute revenue for some time. This lands days after the Q3 10-Q confirmed the cyberattack cut gross margin to 66.7% and after Q4 guidance came in below consensus, so it's a rare piece of good news in a rough stretch. No approval timeline or financial terms beyond the $455 million were disclosed.

At the time of this announcement, BSX was trading at $44.16 on NYSE in the Life Sciences sector, with a market capitalization of approximately $64.2B. The 52-week trading range was $39.57 to $105.65. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

BSX - Latest Insights

BSX
Nov 02, 2026, 5:26 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $44.24
Real-time Price: $43.72 info
Change: -$0.520 (-1%) info
Market Cap: $63.327B info
BSX
Oct 29, 2026, 3:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $42.15
Real-time Price: $43.72 info
Change: +$1.57 (+4%) info
Market Cap: $63.327B info
BSX
Oct 28, 2026, 10:52 AM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $42.11
Real-time Price: $43.72 info
Change: +$1.62 (+4%) info
Market Cap: $63.327B info
BSX
Oct 28, 2026, 6:34 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $42.85
Real-time Price: $43.72 info
Change: +$0.870 (+2%) info
Market Cap: $63.327B info
BSX
Oct 28, 2026, 6:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $45.39
Real-time Price: $43.72 info
Change: -$1.67 (-4%) info
Market Cap: $63.327B info